Lantian Ma
About Lantian Ma
Lantian Ma is the General Manager for Bristol Myers Squibb in Thailand, with extensive experience in the pharmaceutical industry and a background in public policy and international relations.
Company
Lantian Ma is currently serving as the General Manager at Bristol Myers Squibb in Thailand. Bristol Myers Squibb is a global biopharmaceutical company dedicated to discovering, developing, and delivering innovative medicines for patients with serious diseases. Lantian Ma’s role involves overseeing the company's operations and business strategies within the region.
Title
Lantian Ma holds the title of General Manager at Bristol Myers Squibb in Thailand. In this role, Ma is responsible for leading the business unit’s performance, managing the Profit and Loss (P&L) accounts, and ensuring the growth and operational efficiency of Bristol Myers Squibb’s endeavors in Thailand.
Education and Expertise
Lantian Ma studied Public Policy at Princeton University, achieving a Master of Public Affairs (MPA) from 1998 to 2001. He also holds a Bachelor of Arts (BA) in International Relations from Fudan University, obtained between 1991 and 1996. Additionally, Ma achieved a Master of Arts (MA) in Comparative Politics from The University of Georgia. His educational background has equipped him with robust analytical and insight generation skills, essential for his management roles.
Background
Lantian Ma has a diverse background with extensive experience in various capacities and sectors. He has served in significant roles at renowned organizations including The Boston Consulting Group, The World Bank, USAID, and Social Impact. His roles have ranged from Consultant-Project Leader to Sr. Private Sector Health Advisor, accumulating a wealth of experience in strategic planning, operations, and market access. His international career spans multiple regions including New York, Shanghai, Washington DC, Moscow, and Bangkok.
Previous Roles at Bristol Myers Squibb
Before becoming General Manager, Lantian Ma held several critical roles at Bristol Myers Squibb. From 2021 to 2023, he served as Director of Southeast Asia Hematology in Bangkok. He also worked as Strategy and Operations Lead for the China and Asia Cluster from 2020 to 2022. These roles allowed him to harness his expertise in strategic planning and operations management, contributing significantly to the company's regional growth and performance.